This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Allergan Pharmaceuticals International Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Devrim Eren: Innovator in Digestive Enzyme Composition
Introduction
Devrim Eren is an accomplished inventor based in Downingtown, PA (US). He has made significant contributions to the field of digestive health through his innovative work on enzyme compositions. His expertise and dedication have led to the development of a unique patent that addresses specific medical needs.
Latest Patents
Devrim Eren holds a patent for a digestive enzyme composition suitable for enteral administration. This invention is directed to a digestive enzyme composition comprising an enterically coated digestive enzyme product, administrable nutritional medium, and a pharmaceutically acceptable low viscosity oily ingredient. The process for preparing this composition involves adding the enterically coated digestive enzyme product to the nutritional medium and oily ingredient. Furthermore, the invention provides a method for treating patients suffering from exocrine pancreatic insufficiency by administering a therapeutically effective dose of the digestive enzyme composition via a feeding tube. He has 1 patent to his name.
Career Highlights
Devrim Eren is currently associated with Allergan Pharmaceuticals International Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His role at Allergan allows him to contribute to advancements in digestive health and patient care.
Collaborations
Devrim has collaborated with notable colleagues such as Ruth Thieroff-Ekerdt and Luigi Boltri. These partnerships have fostered a collaborative environment that enhances the development of innovative healthcare solutions.
Conclusion
Devrim Eren's contributions to the field of digestive health through his patented enzyme composition demonstrate his commitment to improving patient outcomes. His work at Allergan Pharmaceuticals International Limited and collaborations with esteemed colleagues further highlight his impact in the industry.